DB
IONS icon

Danske Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Danske Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.93K Hold
100
– – ﹤0.01% 856
2026
Q1 		$7.51K Sell
100
-1,300
-93% -$103K ﹤0.01% 851
2025
Q4 		$111K Hold
1,400
– – ﹤0.01% 761
2025
Q3 		$91.6K Hold
1,400
– – ﹤0.01% 882
2025
Q2 		$55.3K Buy
1,400
+900
+180% +$29.5K ﹤0.01% 1003
2025
Q1 		$15.1K Hold
500
– – ﹤0.01% 1017
2024
Q4 		$17.5K Sell
500
-1,600
-76% -$59.8K ﹤0.01% 1017
2024
Q3 		$84.1K Buy
2,100
+1,700
+425% +$79.1K ﹤0.01% 1062
2024
Q2 		$19.1K Buy
+400
New +$16.4K ﹤0.01% 1063

Other funds holding IONS

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Danske Bank's IONS Position: Q2 2026 in Review

Danske Bank held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 100 shares worth $7.93K. The position accounts for ﹤0.01% of the portfolio, ranked #856.

Danske Bank first reported a position in IONS in Q2 2024 and has held it in 9 quarters since. The position peaked at $111K in Q4 2025. 400 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Danske Bank held 100 shares of Ionis Pharmaceuticals worth $7.93K as of Q2 2026.
  • Danske Bank left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #856 holding.
  • Danske Bank first reported a position in Ionis Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Danske Bank's Ionis Pharmaceuticals position peaked at $111K in Q4 2025.
  • 400 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.